Dr Nick Douglas

Senior Research Fellow


Fellow of the Royal Australasian College of Physicians (FRACP), Royal Australasian College of Physicians, 2020; Doctor of Philosophy (DPhil), University of Oxford, 2013; Master of Science (MSc), University of Oxford, 2008; Bachelor of Medicine and Bachelor of Surgery (MBChB), University of Otago, 2006; Bachelor of Medical Science with Honours (BMedSc(hons)), University of Otago, 2004


Darwin - Royal Darwin Hospital campus


Nick is an Infectious Diseases Physician at Royal Darwin Hospital and a post-doctoral Senior Research Fellow in the Global and Tropical Health Division at Menzies School of Health Research. His particular interests include the haematological consequences of vivax malaria, Plasmodium vivax relapse dynamics and prevention and medical statistics. More recently he has also published on COVID-19 and bacteraemia in the Top End of Australia.

  • SHEPPI study: Strengthening Health Systems for Effective Primaquine in Papua Indonesia
  • Estimating the risk of severe vivax malarial illness: a systematic review and meta-analysis
  1. Thriemer K, Poespoprodjo JR, Kenangalem E, Douglas NM, Sugiarto P, Anstey NM, Simpson JA, Price RN. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia. PLoS Neglected Tropical Diseases 2020. In Press.
  2. Douglas NM, Meumann EM, Krause VL, Davies J. Successful containment to date of SARS-CoV-2 transmission in the Northern Territory. Medical Journal of Australia 2020. In Press. DOI: 10.5694/mja2.50840
  3. Douglas NM, Hennessy JN, Currie BJ, Baird RW. Trends in bacteremia over 2 decades in the Top End of the Northern Territory of Australia. Open Forum Infectious Diseases 2020. In Press.
  4. Baird RW and Douglas NM. Re: Epidemiology of Escherichia coli bacteraemia: a systematic literature review. Clinical Infectious Diseases 2020. In Press.
  5. Douglas NM, Baird RW, Currie BJ. Use of a rapid faeces multiplex PCR assay for diagnosis of amoebic liver abscess. Pathology 2020, 52(6), 725-727.
  6. Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, Price RN, Simpson JA. BMC Medicine 2020, 18(1):28.
  7. Douglas NM, Kenangalem E, Hasanuddin A, Anstey NM, Sugiarto P, Price RN, Poespoprodjo JR. Malaria-related hospitalization during childhood in Papua, Indonesia: a retrospective cohort study. PLoS One 2020, 15(1): e0228018.
  8. Ley B, Winasti Satyagraha A, Rahmat H, von Fricken ME, Douglas NM, Pfeffer DA, Espino F, von Seidlein L, Henriques G, Oo NN, Menard D, Parikh S, Bancone G, Karahalios A, Price RN. Performance of the access bio/carestart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. PLoS Medicine 2019, 16(12): e1002992.
  9. Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, Lampah DA, Douglas NM, Anstey NM, Simpson JA, Price RN, Poespoprodjo JR. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infectious Diseases 2019, 19(1):922.
  10. Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas NM, Abreha T, Alemu SG, Anez A, Anstey NM, Aseffa A, Assefa A, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, D’Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Grigg MJ, Hwwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Taylor WRJ, Thwaites G, Tran BQ, Hien TT, Vieira JLF, Wangchuk S, Watson J, William T, Woodrow CJ, Nosten G, Guerin PJ, White NJ, Price RN. The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. BMC Medicine 2019, 17(1):151.